Thomas Thomas T.'s Form 4 filing
Opiant Pharmaceuticals, Inc. (OPNT) · filed Sep 16, 2021
- Accession no.
- 0001385508-21-000136
- Filed
- Sep 16, 2021
- Trade date
- Sep 14, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions and 3 derivative transactions. Open-market sales total $30.4K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thomas Thomas T.CIK 0001689819 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 | Common Stock | MOption exerciseAcquired | +25 | $10.00 | +$250 | 6,678 | Direct | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −15 | $18.95 | −$284.25 | 6,663 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseAcquired | +1,500 | $10.00 | +$15,000 | 8,163 | Direct | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −792 | $19.06 | −$15,095.52 | 7,371 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseAcquired | +1,500 | $10.00 | +$15,000 | 8,871 | Direct | |
| Sep 14, 2021 | Common Stock | SSaleDisposed | −764 | $19.70 | −$15,050.8 | 8,107 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 14, 2021 | Common Stock | MOption exerciseDisposed | −25 | $0.00 | $0 | 6,834 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 5,334 | Direct | |
| Sep 14, 2021 | Common Stock | MOption exerciseDisposed | −1,500 | $0.00 | $0 | 3,834 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.